How to compare results from open with endovascular procedures?
- PMID: 29745216
- DOI: 10.23736/S0021-9509.18.10525-8
How to compare results from open with endovascular procedures?
Abstract
Background: According to the guidelines, bypass surgery is still the golden standard treatment in patients with femoropopliteal TASC C and D lesions and life-style limiting claudication or critical limb ischemia. Over the past few decades, endovascular therapy has made great advancements. However, the success rates of surgical and endovascular procedures cannot be directly compared. According to the surgical term "patency," vessel patency can be maintained even in case of a high grade stenosis, whereas according to the endovascular primary patency definition, being binary restenosis, patency is lost from the moment there is a re-narrowing at any location within the treated segment.
Methods: One hundred consecutive patients with a previously implanted femoropopliteal bypass which was primary patent according to the surgical definition were included in this study. Once enrolled, duplex ultrasonography was performed, measuring the Peak Systolic Velocity Ratio for proximal and distal anastomosis.
Results: Out of the 100 bypasses that were considered patent according to the surgical definition, Peak Velocity Ratio of ≥2.4 were detected in 11 patients.
Conclusions: Based on these findings a 78% primary patency according to the open vascular criteria turned into ~70% primary patency using the stricter endovascular criteria. In the light of these findings, one might conclude that modern endovascular treatment of long TASC C and D femoropopliteal lesions yielded similar results in terms of primary patency as above-the-knee bypasses.
Similar articles
-
Factors Affecting Long-Term Results of Above-Knee Femoropopliteal Bypass: A Single-Center Contemporary Study.Vasc Endovascular Surg. 2016 Feb;50(2):72-9. doi: 10.1177/1538574415627866. Vasc Endovascular Surg. 2016. PMID: 26983664
-
Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.J Vasc Surg. 2017 Jul;66(1):130-142.e1. doi: 10.1016/j.jvs.2017.01.065. Epub 2017 Apr 8. J Vasc Surg. 2017. PMID: 28400218 Clinical Trial.
-
Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.Ann Vasc Surg. 2018 Feb;47:179-187. doi: 10.1016/j.avsg.2017.09.008. Epub 2017 Sep 22. Ann Vasc Surg. 2018. PMID: 28943491
-
A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.J Vasc Surg. 2014 Aug;60(2):506-15. doi: 10.1016/j.jvs.2014.05.049. Epub 2014 Jun 25. J Vasc Surg. 2014. PMID: 24973288 Review.
-
Peak systolic velocity ratio derived from quantitative vessel analysis for restenosis after femoropopliteal intervention: a multidisciplinary review from Endovascular Asia.Cardiovasc Interv Ther. 2020 Jan;35(1):52-61. doi: 10.1007/s12928-019-00602-z. Epub 2019 Jul 11. Cardiovasc Interv Ther. 2020. PMID: 31292931 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous